More Defensive Stocks on Sale
These high-quality names are resilient and undervalued.
On-again, off-again U.S.-China trade tensions. An inverted yield curve. Worries about global economic growth. These factors have injected a good deal of uncertainty into the market during the past two weeks. Whether or not stocks continue their upward march is anyone’s guess. But playing a little bit of defense with your stock portfolio may not be the worst idea.
Last week, we shared some inexpensive, defensive stock ideas. Specifically, we homed in on stocks in Morningstar’s Defensive Super Sector, which includes the healthcare, consumer defensive, and utilities sectors--pockets of the market that are generally immune to economic cycles. We then narrowed the field further by screening for names with Morningstar Economic Moat Ratings of wide or narrow within that Super Sector, ensuring that we were cherry-picking only the financially healthiest and most profitable companies. We tossed out stocks with high or greater Morningstar Uncertainty Ratings, thereby eliminating companies with less predictable cash flows. And lastly, we demanded that these defensive names be trading at Morningstar Ratings of 5 stars--significantly below our fair value estimates. Just nine stocks made the cut.
Susan Dziubinski does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.